Quest Diagnostics, Inc. (DGX) Misses Q4 EPS by 7c; Guides Below Street
Quest Diagnostics, Inc. (NYSE: DGX) reported Q4 EPS of $1.01, $0.07 worse than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
